Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel

被引：32

作者：

Cury-Martins, Jade ^{[1
,7
]}

Mendes Eris, Adriana Pessoa ^{[2
,3
,7
]}

Zugaib Abdalla, Cristina Martinez ^{[4
,7
]}

Silva, Giselle de Barros ^{[5
,7
]}

Torel de Moura, Veronica Paula ^{[6
,7
]}

Sanches, Jose Antonio ^{[1
,7
]}

机构：

[1] Univ Sao Paulo, Hosp Clin, Fac Med, Dept Dermatol, Sao Paulo, SP, Brazil

[2] Santa Casa Misericordia Sao Paulo, Dermatol Clin, Sao Paulo, SP, Brazil

[3] AC Camargo Canc Ctr, Skin Canc Unit, Sao Paulo, SP, Brazil

[4] Hosp Sirio Libanes, Dermatol Unit, Sao Paulo, SP, Brazil

[5] Ctr Paulista Oncol, Dermatol Unit, Sao Paulo, SP, Brazil

[6] Hosp Beneficencia Portuguesa Sao Paulo, Oncol Ctr, Sao Paulo, SP, Brazil

[7] Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil

来源：

ANAIS BRASILEIROS DE DERMATOLOGIA | 2020年 / 95卷 / 02期

关键词：

Antineoplastic agents; immunological; Dermatology; Drug-related side effects and adverse reactions; Medical oncology; Molecular targeted therapy; FOOT SKIN REACTION; CHEMOTHERAPY-INDUCED ALOPECIA; IMMUNE CHECKPOINT INHIBITORS; FACTOR RECEPTOR INHIBITORS; SCALP COOLING DEVICE; UREA-BASED CREAM; PHASE-II TRIAL; TARGETED THERAPIES; PREVENTION STRATEGIES; MELANOMA PATIENTS;

D O I：

10.1016/j.abd.2020.01.001

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences. (C) 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier Espana, S.L.U.

引用

页码：221 / 237

页数：17

共 50 条

[11] Dermatologic Adverse Events to Targeted Therapies in Lower GI Cancers: Clinical Presentation and Management
Viswanath Reddy Belum
Andrea Cercek
Virginia Sanz-Motilva
Mario E. Lacouture
Current Treatment Options in Oncology, 2013, 14 : 389 - 404
[12] Dermatologic Adverse Events to Targeted Therapies in Lower GI Cancers: Clinical Presentation and Management
Belum, Viswanath Reddy
Cercek, Andrea
Sanz-Motilva, Virginia
Lacouture, Mario E.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (03) : 389 - 404
[13] Management of important adverse events associated with inotuzumab ozogamicin: expert panel review
Partow Kebriaei
Corey Cutler
Marcos de Lima
Sergio Giralt
Stephanie J. Lee
David Marks
Akil Merchant
Wendy Stock
Koen van Besien
Matthias Stelljes
Bone Marrow Transplantation, 2018, 53 : 449 - 456
[14] Management of important adverse events associated with inotuzumab ozogamicin: expert panel review
Kebriaei, Partow
Cutler, Corey
de Lima, Marcos
Giralt, Sergio
Lee, Stephanie J.
Marks, David
Merchant, Akil
Stock, Wendy
van Besien, Koen
Stelljes, Matthias
BONE MARROW TRANSPLANTATION, 2018, 53 (04) : 449 - 456
[15] Top-priority actions for preventing adverse drug events in hospitals - Recommendations of an expert panel
Bates, DW
Burrows, AM
Grossman, DGS
Schneider, PJ
Strom, BL
Myers, CE
Cranston, JW
ONeal, DJ
Cohen, SS
Cousins, DD
Fink, L
Mundt, RL
Nadzam, D
King, CM
Santell, JP
Wilfinger, RG
Zellmer, WA
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (07) : 747 - 751
[16] Overview and Management of Dermatologic Events Associated with Targeted Therapies for Medullary Thyroid Cancer
Lacouture, Mario E.
Ciccolini, Kathryn
Kloos, Richard T.
Agulnik, Mark
THYROID, 2014, 24 (09) : 1329 - 1340
[17] Management of patients with recurrent/metastatic endometrial cancer: Consensus recommendations from an expert panel from Brazil
de Andrade, Diocesio Alves Pinto
Guimaraes, Andrea Paiva Gadelha
de Melo, Andreia Cristina
Nogueira-Rodrigues, Angelica
Gomes, Larissa Müller
Scaranti, Mariana
Maia, Joyce Maria Lisboa
Morelle, Alessandra Menezes
Santos, Candice Amorim de Araujo Lima
Souza, Cristiano de Padua
de Freitas, Daniela
Callegaro Filho, Donato
Paulino, Eduardo
Araujo, Elge Werneck
Pimenta, Juliana Martins
dos Santos, Marcela Bonalumi
de Almeida, Michelle Samora
Souza, Ronaldo Pereira
Cabral, Samantha
Maluf, Fernando Cotait
FRONTIERS IN ONCOLOGY, 2023, 13
[18] Dermatologic adverse events of the new targeted anticancer therapies used in oncodermatology
Sibaud, V.
Delord, J. -P.
Chevreau, C.
Gangloff, D.
Garrido-Stowhas, I.
ANNALES DE CHIRURGIE PLASTIQUE ESTHETIQUE, 2012, 57 (02): : 106 - 113
[19] Impact of dermatologic adverse events induced by targeted therapies on quality of life
Charles, Cecile
Bungener, Catherine
Razavi, Darius
Mateus, Christine
Routier, Emilie
Lanoy, Emilie
Verschoore, Michele
Robert, Caroline
Dauchy, Sarah
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 101 : 158 - 168
[20] Considerations for the Identification and Management of Geographic Atrophy : Recommendations from an Expert Panel
Regillo, Carl D.
Nijm, Lisa M.
Shechtman, Diana L.
Kaiser, Peter K.
Karpecki, Paul M.
Ryan, Edwin H.
Ip, Michael S.
Yeu, Elizabeth
Kim, Terry
Rafieetary, Mohammad R.
Donnenfeld, Eric D.
CLINICAL OPHTHALMOLOGY, 2024, 18 : 325 - 335

← 1 2 3 4 5 →